128 related articles for article (PubMed ID: 31916647)
1. Perceived fatigue in children and young adults with neurofibromatosis type 1.
Vassallo G; Mughal Z; Robinson L; Weisberg D; Roberts SA; Hupton E; Eelloo J; Burkitt Wright EM; Garg S; Lewis L; Evans DG; Stivaros SM
J Paediatr Child Health; 2020 Jun; 56(6):878-883. PubMed ID: 31916647
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
[TBL] [Abstract][Full Text] [Related]
3. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity.
Varni JW; Burwinkle TM; Szer IS
J Rheumatol; 2004 Dec; 31(12):2494-500. PubMed ID: 15570657
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal Symptoms in Children and Adolescents With Neurofibromatosis Type 1.
Ejerskov C; Krogh K; Ostergaard JR; Joensson I; Haagerup A
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):872-875. PubMed ID: 29240009
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of sleep disorders in patients with neurofibromatosis type 1.
Maraña Pérez AI; Duat Rodríguez A; Soto Insuga V; Domínguez Carral J; Puertas Martín V; González Gutiérrez Solana L
Neurologia; 2015; 30(9):561-5. PubMed ID: 24975344
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Multidimensional Fatigue After Childhood Brain Injury.
Crichton AJ; Babl F; Oakley E; Greenham M; Hearps S; Delzoppo C; Hutchison J; Beauchamp M; Anderson VA
J Head Trauma Rehabil; 2017; 32(2):107-116. PubMed ID: 27455435
[TBL] [Abstract][Full Text] [Related]
7. Height assessments in children with neurofibromatosis type 1.
Soucy EA; van Oppen D; Nejedly NL; Gao F; Gutmann DH; Hollander AS
J Child Neurol; 2013 Mar; 28(3):303-7. PubMed ID: 22752476
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Impact of Fatigue in Children with Primary Immunodeficiency Disorders: a Quantitative Single-Center Study.
Visser E; Fraaij P; Hoogenboom A; Witkamp E; van der Knaap L; van Rossum A; Stol K; Vermont C
J Clin Immunol; 2022 Aug; 42(6):1223-1229. PubMed ID: 35536474
[TBL] [Abstract][Full Text] [Related]
9. The PedsQL multidimensional fatigue scale in pediatric obesity: feasibility, reliability and validity.
Varni JW; Limbers CA; Bryant WP; Wilson DP
Int J Pediatr Obes; 2010; 5(1):34-42. PubMed ID: 19593727
[TBL] [Abstract][Full Text] [Related]
10. PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity.
Nutakki K; Varni JW; Swigonski NL
J Neurooncol; 2018 Apr; 137(2):337-347. PubMed ID: 29273891
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
Ringold S; Wallace CA; Rivara FP
J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
[TBL] [Abstract][Full Text] [Related]
12. L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.
Vasiljevski ER; Burns J; Bray P; Donlevy G; Mudge AJ; Jones KJ; Summers MA; Biggin A; Munns CF; McKay MJ; Baldwin JN; Little DG; Schindeler A
Am J Med Genet A; 2021 Oct; 185(10):2976-2985. PubMed ID: 34155781
[TBL] [Abstract][Full Text] [Related]
13. Fractures in children with neurofibromatosis type 1 from two NF clinics.
George-Abraham JK; Martin LJ; Kalkwarf HJ; Rieley MB; Stevenson DA; Viskochil DH; Hopkin RJ; Stevens AM; Hanson H; Schorry EK
Am J Med Genet A; 2013 May; 161A(5):921-6. PubMed ID: 23529831
[TBL] [Abstract][Full Text] [Related]
14. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.
Varni JW; Burwinkle TM; Katz ER; Meeske K; Dickinson P
Cancer; 2002 Apr; 94(7):2090-106. PubMed ID: 11932914
[TBL] [Abstract][Full Text] [Related]
15. The PedsQL Multidimensional Fatigue Scale in type 1 diabetes: feasibility, reliability, and validity.
Varni JW; Limbers CA; Bryant WP; Wilson DP
Pediatr Diabetes; 2009 Aug; 10(5):321-8. PubMed ID: 19067887
[TBL] [Abstract][Full Text] [Related]
16. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
[TBL] [Abstract][Full Text] [Related]
17. Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.
Rosenberg AGW; Mochèl K; Hähner LM; Ruules L; Davidse K; Bos-Roubos AG; van Dijk SA; Zillikens MC; Taal W; van der Lely AJ; de Graaff LCG
Front Endocrinol (Lausanne); 2023; 14():1119159. PubMed ID: 38560379
[TBL] [Abstract][Full Text] [Related]
18. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior.
Krab LC; Oostenbrink R; de Goede-Bolder A; Aarsen FK; Elgersma Y; Moll HA
J Pediatr; 2009 Mar; 154(3):420-5, 425.e1. PubMed ID: 18950800
[TBL] [Abstract][Full Text] [Related]
20. Bedtime digital media use, sleep and fatigue among survivors of childhood cancer, their siblings and healthy control sibling pairs.
Merz EL; Russell KB; Sell H; Schulte F; Reynolds K; Tomfohr-Madsen L
Psychol Health Med; 2023; 28(8):2137-2146. PubMed ID: 37249906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
